Lumos Pharma, Inc. (LUMO) Posts FY21 Loss of $3.65/Share

Lumos Pharma, Inc. (NASDAQ: LUMO) reported FY21 EPS of $(3.65), versus ($0.93) last year. Revenue for the year came in at $230K, versus $168K reported last year.

For earnings history and earnings-related data on Lumos Pharma, Inc. (LUMO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c